Rafael Andrade Caceres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rafael Andrade Caceres has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Walter Filgueira de Azevedo
Department of Physics, Institute of Exact Sciences, Federal University of Alfenas, Av. Jovino Fernandes de Sales 2600, Bairro Santa Clara, Alfenas, MG., 37133-840, Brazil
25 shared publications - Luiz Augusto Basso
Pontifícia Universidade Católica do Rio Grande do Sul, Brasil
12 shared publications Ivani Pauli
Faculdade de Biociências, Instituto Nacional de Ciência e Tecnologia em Tuberculose-CNPq, Laboratório de Bioquímica Estrutural, Pontifícia Universidade Católica do Rio Grande do Sul, PUCRS, Porto Alegre, RS, Brazil
10 shared publicationsLuis Fernando Saraiva Macedo Timmers
Laboratory for Bioinformatics, Modelling and Simulation of Biosystems-LABIO, Pontifical Catholic University of Rio Grande do Sul-PUCRS, Porto Alegre City, Brazil; Graduate Program in Cellular and Molecular Biology (PPGBCM), PUCRS, Porto Alegre, RS, Brazil
10 shared publicationsRaquel Dias
6 shared publications- Diógenes Santiago Santos
Instituto Nacional de Ciência e Tecnologia em Tuberculose, Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, 90619-900, Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, 90619-900, Porto Alegre, Rio Grande do Sul, Brazil
5 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
The mTOR-mLST8 binding profile through molecular simulation, free-energy calculation, per-residue decomposition and hydrogen bonds identification
- 10 April 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Open AccessThe mTOR-mLST8 binding profile through molecular simulation, free-energy calculation, per-residue decomposition and hydrogen bonds identification
- Open Access
- 28 December 2023
- Published by Tecnologico de Antioquia Institucion Universitaria in Revista En-contexto
- Vol. 11 (20) , 53-73
Reparación colectiva como enfoque alternativo. Un estudio desde las víctimas y otros procesos de paz en el mundo
Colombia suma más de 9 millones de víctimas y la cifra sigue en aumento. La protección de los derechos de las víctimas —verdad, justicia, reparación y garantías de no repetición— implica una elevada inversión por parte del Estado colombiano que supera su capacidad fiscal. El objetivo de este artículo es analizar la viabilidad de aplicar el enfoque de reparación colectiva en el marco de la reparación de víctimas en Colombia. Corresponde a una investigación cualitativa enmarcada en el paradigma sistémico y el método hermenéutico. Participaron en el estudio treinta víctimas del conflicto armado indemnizadas y con residencia en el municipio de Cúcuta, a quienes se les aplicó una entrevista semiestructura. Los datos fueron codificados y categorizados, y analizados a través del software ATLAS ti. Los resultados muestran que la aplicación de enfoque de reparación colectiva exigiría de políticas y estrategias diseñadas y ajustadas a la real participación de las víctimas, y que existen serias barreras para su implementación. Se concluye que los enfoques de paz imperfecta y reparación colectiva pueden guiar los programas y los planes vinculados a la reparación de las víctimas del Acuerdo de Paz, superando las limitaciones fiscales y procurando la configuración de una reparación transformadora.
- 28 December 2023
- Published by Tecnologico de Antioquia Institucion Universitaria in Revista En-contexto
- Vol. 11 (20) , 53-73
Open AccessReparación colectiva como enfoque alternativo. Un estudio desde las víctimas y otros procesos de paz en el mundo
Colombia suma más de 9 millones de víctimas y la cifra sigue en aumento. La protección de los derechos de las víctimas —verdad, justicia, reparación y garantías de no repetición— implica una elevada inversión por parte del Estado colombiano que supera su capacidad fiscal. El objetivo de este artículo es analizar la viabilidad de aplicar el enfoque de reparación colectiva en el marco de la reparación de víctimas en Colombia. Corresponde a una investigación cualitativa enmarcada en el paradigma sistémico y el método hermenéutico. Participaron en el estudio treinta víctimas del conflicto armado indemnizadas y con residencia en el municipio de Cúcuta, a quienes se les aplicó una entrevista semiestructura. Los datos fueron codificados y categorizados, y analizados a través del software ATLAS ti. Los resultados muestran que la aplicación de enfoque de reparación colectiva exigiría de políticas y estrategias diseñadas y ajustadas a la real participación de las víctimas, y que existen serias barreras para su implementación. Se concluye que los enfoques de paz imperfecta y reparación colectiva pueden guiar los programas y los planes vinculados a la reparación de las víctimas del Acuerdo de Paz, superando las limitaciones fiscales y procurando la configuración de una reparación transformadora.
- Open Access
Developing QSAR Models for the Identification of Inhibitors Targeting Mycobacterium tuberculosis Enoyl-ACP Reductase Enzyme
Tuberculosis is a global concern due to its high prevalence in developing countries and the ability of mycobacteria to develop resistance to current treatment regimens. In this project, we propose the use of QSAR (Quantitative Structure-Activity Relationships) modeling as a means to identify and evaluate the inhibitory activity of candidate molecules for molecular improvement stages and/or in vitro assays. This approach allows for in silico estimation, reducing research time and costs. To achieve this, we utilized the SAR (Structure-Activity Relationships) study conducted by He, Alian, and Montellano (2007), which focused on a series of arylamides tested as inhibitors of the enzyme enoyl-ACP-reductase (InhA) in Mycobacterium tuberculosis . We developed both the Hansh-Fujita (classical) and CoMFA (Comparative Molecular Field Analysis) QSAR models. The classical QSAR model produced the most favorable statistical results using Multiple Linear Regression (MLR). It achieved an internal validation correlation factor R 2 of 0.9012 and demonstrated predictive quality with a Stone-Geisser indicator Q 2 of 0.8612. External validation resulted in a correlation factor R 2 of 0.9298 and Q 2 of 0.720, indicating a highly predictive mathematical model. The CoMFA Model obtained a Q 2 of 0.6520 in internal validation, enabling the estimation of energy fields around the molecules. This information is crucial for molecular improvement efforts. We constructed a library of small molecules, analogous to those used in the SAR study, and subjected them to the classic QSAR function. As a result, we identified ten molecules with high estimated biological activity. Molecular docking analysis suggests that these ten analogs, identified by the classical QSAR model, exhibit favorable estimated free energy of binding. In conclusion, the QSAR methodology proves to be an efficient and effective tool for searching and identifying promising drug-like molecules.
Open AccessDeveloping QSAR Models for the Identification of Inhibitors Targeting Mycobacterium tuberculosis Enoyl-ACP Reductase Enzyme
Tuberculosis is a global concern due to its high prevalence in developing countries and the ability of mycobacteria to develop resistance to current treatment regimens. In this project, we propose the use of QSAR (Quantitative Structure-Activity Relationships) modeling as a means to identify and evaluate the inhibitory activity of candidate molecules for molecular improvement stages and/or in vitro assays. This approach allows for in silico estimation, reducing research time and costs. To achieve this, we utilized the SAR (Structure-Activity Relationships) study conducted by He, Alian, and Montellano (2007), which focused on a series of arylamides tested as inhibitors of the enzyme enoyl-ACP-reductase (InhA) in Mycobacterium tuberculosis . We developed both the Hansh-Fujita (classical) and CoMFA (Comparative Molecular Field Analysis) QSAR models. The classical QSAR model produced the most favorable statistical results using Multiple Linear Regression (MLR). It achieved an internal validation correlation factor R 2 of 0.9012 and demonstrated predictive quality with a Stone-Geisser indicator Q 2 of 0.8612. External validation resulted in a correlation factor R 2 of 0.9298 and Q 2 of 0.720, indicating a highly predictive mathematical model. The CoMFA Model obtained a Q 2 of 0.6520 in internal validation, enabling the estimation of energy fields around the molecules. This information is crucial for molecular improvement efforts. We constructed a library of small molecules, analogous to those used in the SAR study, and subjected them to the classic QSAR function. As a result, we identified ten molecules with high estimated biological activity. Molecular docking analysis suggests that these ten analogs, identified by the classical QSAR model, exhibit favorable estimated free energy of binding. In conclusion, the QSAR methodology proves to be an efficient and effective tool for searching and identifying promising drug-like molecules.
- 12 August 2021
- Published by Taylor & Francis in Molecular Simulation
- Vol. 47 (14) , 1198-1207
Understanding the role of mTOR-mLst8 binding through coarse-grained simulation approaches
The kinase called mechanistic Target of Rapamycin (mTOR) belongs to a complex network pathway responsible for many physiological mechanisms, responses to multiple factors and usually is deregulated in various types of diseases. In vitro studies support the idea that the binding of mammalian lethal with SEC13 protein 8 (mLst8) subunit on mTOR is necessary to initiate the kinase phosphotransference process. Thus, the mLst8 subunit is important for the regulation of mTOR complex, but its function, especially on catalytic site, needs to be defined. In addition, the contribution of mLst8 to the development and control of pathologies, particularly those in which the mTOR pathways seems deregulated, remains unsolved or with few available data and could be an important step to develop new strategies avoiding the superexpression of this pathway. In our study, we employed coarse-grained molecular dynamics simulation to analyse the behaviour of the mTOR catalytic site when the subunit mLst8 is associated or not, providing insights about the importance of mTOR-mLst8 interaction for the kinase mechanism. GRAPHICAL ABSTRACT
- 12 August 2021
- Published by Taylor & Francis in Molecular Simulation
- Vol. 47 (14) , 1198-1207
Understanding the role of mTOR-mLst8 binding through coarse-grained simulation approaches
The kinase called mechanistic Target of Rapamycin (mTOR) belongs to a complex network pathway responsible for many physiological mechanisms, responses to multiple factors and usually is deregulated in various types of diseases. In vitro studies support the idea that the binding of mammalian lethal with SEC13 protein 8 (mLst8) subunit on mTOR is necessary to initiate the kinase phosphotransference process. Thus, the mLst8 subunit is important for the regulation of mTOR complex, but its function, especially on catalytic site, needs to be defined. In addition, the contribution of mLst8 to the development and control of pathologies, particularly those in which the mTOR pathways seems deregulated, remains unsolved or with few available data and could be an important step to develop new strategies avoiding the superexpression of this pathway. In our study, we employed coarse-grained molecular dynamics simulation to analyse the behaviour of the mTOR catalytic site when the subunit mLst8 is associated or not, providing insights about the importance of mTOR-mLst8 interaction for the kinase mechanism. GRAPHICAL ABSTRACT
- 15 September 2018
- Published by Wiley in Journal of Computational Chemistry
- Vol. 39 (24) , 2000-2011
Prion protein conversion triggered by acidic condition: a molecular dynamics study through different force fields
Prions are proteins that cause a group of invariably fatal neurodegenerative diseases, one of the most known being bovine spongiform encephalopathy. The three‐dimensional structure of PrPSc, the altered isoform of the prion protein, has not been fully elucidated yet, and studies on prion conversion mechanisms must rely on hypothetical β‐rich structures. Experimental and computational studies indicate that the use of low pH is capable to produce a gain of β‐structure content in the otherwise unstructured N‐terminal region. These in silico studies have used different PrP fragments from distinct organisms, and with different lengths and simulation protocols, making it difficult to identify the influence of the force fields on the formation of such structures. Here, we performed a systematic study of the influence of six well‐established force fields (GROMOS96 53a6, GROMOS96 43a1, AMBER99SB, AMBER99SB‐ILDN, CHARMM27, and OPLS‐AA/L) on the process of structural conversion of the Syrian hamster cellular prion protein simulated at acidic and neutral pH. From our analysis, we observe a strong dependence of the results with the different force fields employed. Additionally, only GROMOS96 53A6 and AMBER99SB force fields are capable to capture a high β‐sheet formation at acidic pH and adequately reproduce the neutral pH. In both cases, the β‐sheet elongation seems to be guided by the movement of the N‐terminal tail toward the N‐terminal of α‐helix HB under acidic condition. These results comprise the most wide‐ranging study to date correlating force fields to structural changes in the cellular prion protein.
- 15 September 2018
- Published by Wiley in Journal of Computational Chemistry
- Vol. 39 (24) , 2000-2011
Prion protein conversion triggered by acidic condition: a molecular dynamics study through different force fields
Prions are proteins that cause a group of invariably fatal neurodegenerative diseases, one of the most known being bovine spongiform encephalopathy. The three‐dimensional structure of PrPSc, the altered isoform of the prion protein, has not been fully elucidated yet, and studies on prion conversion mechanisms must rely on hypothetical β‐rich structures. Experimental and computational studies indicate that the use of low pH is capable to produce a gain of β‐structure content in the otherwise unstructured N‐terminal region. These in silico studies have used different PrP fragments from distinct organisms, and with different lengths and simulation protocols, making it difficult to identify the influence of the force fields on the formation of such structures. Here, we performed a systematic study of the influence of six well‐established force fields (GROMOS96 53a6, GROMOS96 43a1, AMBER99SB, AMBER99SB‐ILDN, CHARMM27, and OPLS‐AA/L) on the process of structural conversion of the Syrian hamster cellular prion protein simulated at acidic and neutral pH. From our analysis, we observe a strong dependence of the results with the different force fields employed. Additionally, only GROMOS96 53A6 and AMBER99SB force fields are capable to capture a high β‐sheet formation at acidic pH and adequately reproduce the neutral pH. In both cases, the β‐sheet elongation seems to be guided by the movement of the N‐terminal tail toward the N‐terminal of α‐helix HB under acidic condition. These results comprise the most wide‐ranging study to date correlating force fields to structural changes in the cellular prion protein.
- 1 March 2018
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 80, 251-263
Searching for potential mTOR inhibitors: Ligand-based drug design, docking and molecular dynamics studies of rapamycin binding site
- 1 March 2018
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 80, 251-263
Searching for potential mTOR inhibitors: Ligand-based drug design, docking and molecular dynamics studies of rapamycin binding site
- 4 October 2017
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 23 (11) , 304
LiGRO: a graphical user interface for protein–ligand molecular dynamics
To speed up the drug-discovery process, molecular dynamics (MD) calculations performed in GROMACS can be coupled to docking simulations for the post-screening analyses of large compound libraries. This requires generating the topology of the ligands in different software, some basic knowledge of Linux command lines, and a certain familiarity in handling the output files. LiGRO—the python-based graphical interface introduced here—was designed to overcome these protein–ligand parameterization challenges by allowing the graphical (non command line-based) control of GROMACS (MD and analysis), ACPYPE (ligand topology builder) and PLIP (protein-binder interactions monitor)—programs that can be used together to fully perform and analyze the outputs of complex MD simulations (including energy minimization and NVT/NPT equilibration). By allowing the calculation of linear interaction energies in a simple and quick fashion, LiGRO can be used in the drug-discovery pipeline to select compounds with a better protein-binding interaction profile. The design of LiGRO allows researchers to freely download and modify the software, with the source code being available under the terms of a GPLv3 license from http://www.ufrgs.br/lasomfarmacia/ligro/ .
- 4 October 2017
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 23 (11) , 304
LiGRO: a graphical user interface for protein–ligand molecular dynamics
To speed up the drug-discovery process, molecular dynamics (MD) calculations performed in GROMACS can be coupled to docking simulations for the post-screening analyses of large compound libraries. This requires generating the topology of the ligands in different software, some basic knowledge of Linux command lines, and a certain familiarity in handling the output files. LiGRO—the python-based graphical interface introduced here—was designed to overcome these protein–ligand parameterization challenges by allowing the graphical (non command line-based) control of GROMACS (MD and analysis), ACPYPE (ligand topology builder) and PLIP (protein-binder interactions monitor)—programs that can be used together to fully perform and analyze the outputs of complex MD simulations (including energy minimization and NVT/NPT equilibration). By allowing the calculation of linear interaction energies in a simple and quick fashion, LiGRO can be used in the drug-discovery pipeline to select compounds with a better protein-binding interaction profile. The design of LiGRO allows researchers to freely download and modify the software, with the source code being available under the terms of a GPLv3 license from http://www.ufrgs.br/lasomfarmacia/ligro/ .
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , 9044-9049
Functional New World monkey oxytocin forms elicit an altered signaling profile and promotes parental care in rats
Significance: Several forms of the oxytocin neurohormone have been found in New World monkeys (NWMs). Previous research has suggested an association between these forms and behaviors typical of this primate branch, including paternal care and monogamy. Our study provides genetic, pharmacological, behavioral, and in silico evidence supporting this connection. Rats treated intranasally with two NWM oxytocin variants showed an increase in some parental care behaviors. The same two variants were found to elicit different cell-signaling profiles in cell-based assays compared with ancestral oxytocin. Our findings highlight how mutations in the OXT DNA sequence coding for a nonapeptide result in distinct signaling profiles that may be linked to the emergence of novel adaptive traits, in this case, paternal care and monogamy.
- 7 August 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (34) , 9044-9049
Functional New World monkey oxytocin forms elicit an altered signaling profile and promotes parental care in rats
Significance: Several forms of the oxytocin neurohormone have been found in New World monkeys (NWMs). Previous research has suggested an association between these forms and behaviors typical of this primate branch, including paternal care and monogamy. Our study provides genetic, pharmacological, behavioral, and in silico evidence supporting this connection. Rats treated intranasally with two NWM oxytocin variants showed an increase in some parental care behaviors. The same two variants were found to elicit different cell-signaling profiles in cell-based assays compared with ancestral oxytocin. Our findings highlight how mutations in the OXT DNA sequence coding for a nonapeptide result in distinct signaling profiles that may be linked to the emergence of novel adaptive traits, in this case, paternal care and monogamy.
- 9 December 2016
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 35 (16) , 3555-3568
New potential inhibitors of mTOR: a computational investigation integrating molecular docking, virtual screening and molecular dynamics simulation
The mTOR (mammalian or mechanistic Target Of Rapamycin), a complex metabolic pathway that involves multiple steps and regulators, is a major human metabolic pathway responsible for cell growth control in response to multiple factors and that is dysregulated in various types of cancer. The classical inhibition of the mTOR pathway is performed by rapamycin and its analogs (rapalogs). Considering that rapamycin binds to an allosteric site and performs a crucial role in the inhibition of the mTOR complex without causing the deleterious side effects common to ATP-competitive inhibitors, we employ ligand-based drug design strategies, such as virtual screening methodology, computational determination of ADME/Tox properties of selected molecules, and molecular dynamics in order to select molecules with the potential to become non-ATP-competitive inhibitors of the mTOR enzymatic complex. Our findings suggest five novel potential mTOR inhibitors, with similar or better properties than the classic inhibitor complex, rapamycin.
- 9 December 2016
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 35 (16) , 3555-3568
New potential inhibitors of mTOR: a computational investigation integrating molecular docking, virtual screening and molecular dynamics simulation
The mTOR (mammalian or mechanistic Target Of Rapamycin), a complex metabolic pathway that involves multiple steps and regulators, is a major human metabolic pathway responsible for cell growth control in response to multiple factors and that is dysregulated in various types of cancer. The classical inhibition of the mTOR pathway is performed by rapamycin and its analogs (rapalogs). Considering that rapamycin binds to an allosteric site and performs a crucial role in the inhibition of the mTOR complex without causing the deleterious side effects common to ATP-competitive inhibitors, we employ ligand-based drug design strategies, such as virtual screening methodology, computational determination of ADME/Tox properties of selected molecules, and molecular dynamics in order to select molecules with the potential to become non-ATP-competitive inhibitors of the mTOR enzymatic complex. Our findings suggest five novel potential mTOR inhibitors, with similar or better properties than the classic inhibitor complex, rapamycin.
- 25 June 2016
- Published by Springer Nature in Archives of Toxicology
- Vol. 90 (9) , 2063-2076
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Anthracyclines, e.g., doxorubicin (DOX), and anthracenediones, e.g., mitoxantrone (MTX), are drugs used in the chemotherapy of several cancer types, including solid and non-solid malignancies such as breast cancer, leukemia, lymphomas, and sarcomas. Although they are effective in tumor therapy, treatment with these two drugs may lead to side effects such as arrhythmia and heart failure. At the same clinically equivalent dose, MTX causes slightly reduced cardiotoxicity compared with DOX. These drugs interact with iron to generate reactive oxygen species (ROS), target topoisomerase 2 (Top2), and impair mitochondria. These are some of the mechanisms through which these drugs induce late cardiomyopathy. In this review, we compare the cardiotoxicities of these two chemotherapeutic drugs, DOX and MTX. As described here, even though they share similarities in their modes of toxicant action, DOX and MTX seem to differ in a key aspect. DOX is a more redox-interfering drug, while MTX induces energy imbalance. In addition, DOX toxicity can be explained by underlying mechanisms that include targeting of Top2 beta, mitochondrial impairment, and increases in ROS generation. These modes of action have not yet been demonstrated for MTX, and this knowledge gap needs to be filled.
- 25 June 2016
- Published by Springer Nature in Archives of Toxicology
- Vol. 90 (9) , 2063-2076
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Anthracyclines, e.g., doxorubicin (DOX), and anthracenediones, e.g., mitoxantrone (MTX), are drugs used in the chemotherapy of several cancer types, including solid and non-solid malignancies such as breast cancer, leukemia, lymphomas, and sarcomas. Although they are effective in tumor therapy, treatment with these two drugs may lead to side effects such as arrhythmia and heart failure. At the same clinically equivalent dose, MTX causes slightly reduced cardiotoxicity compared with DOX. These drugs interact with iron to generate reactive oxygen species (ROS), target topoisomerase 2 (Top2), and impair mitochondria. These are some of the mechanisms through which these drugs induce late cardiomyopathy. In this review, we compare the cardiotoxicities of these two chemotherapeutic drugs, DOX and MTX. As described here, even though they share similarities in their modes of toxicant action, DOX and MTX seem to differ in a key aspect. DOX is a more redox-interfering drug, while MTX induces energy imbalance. In addition, DOX toxicity can be explained by underlying mechanisms that include targeting of Top2 beta, mitochondrial impairment, and increases in ROS generation. These modes of action have not yet been demonstrated for MTX, and this knowledge gap needs to be filled.